Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.
- DOI
- 10.1016/j.autrev.2026.104081
- Published
- 2026 Jul
- Container
- Autoimmunity reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.autrev.2026.104081,
title = {Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.},
author = {Chioni A and Campochiaro C and Keret S and Panopoulos S and Barešić M and Varelas G and Radić M and Sebastiani M and Tektonidou MG and Sfikakis PP and Rimar D and Matucci-Cerinic M and Daoussis D},
year = {2026},
journal = {Autoimmunity reviews},
doi = {10.1016/j.autrev.2026.104081},
url = {https://doi.org/10.1016/j.autrev.2026.104081}
}RIS
TY - JOUR TI - Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study. AU - Chioni A AU - Campochiaro C AU - Keret S AU - Panopoulos S AU - Barešić M AU - Varelas G AU - Radić M AU - Sebastiani M AU - Tektonidou MG AU - Sfikakis PP AU - Rimar D AU - Matucci-Cerinic M AU - Daoussis D PY - 2026 JO - Autoimmunity reviews DO - 10.1016/j.autrev.2026.104081 UR - https://doi.org/10.1016/j.autrev.2026.104081 ER -
APA
A, C., C, C., S, K., S, P., M, B., G, V., M, R., M, S., MG, T., PP, S., D, R., M, M., & D, D. (2026). Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.. Autoimmunity reviews. https://doi.org/10.1016/j.autrev.2026.104081
Source records
- pubmed · retrieved 2026-09-26T21:03:50.220Z